Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 13Other hematologic neoplasm 12Plasma cell 7Dermatologic 6Myeloid 5Genitourinary 4Breast 4Head & Neck 3Thoracic 2Sarcoma 2Gynecologic 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1

Interventions

Cisplatin 314Radiotherapy 139Cetuximab 132pembrolizumab 131Docetaxel 121Carboplatin 119Radiotherapy, Intensity-Modulated 97Fluorouracil 94Paclitaxel 92Nivolumab 64Gemcitabine 50toripalimab 46Radiation 44Drug Therapy 39Capecitabine 39Magnetic Resonance Spectroscopy 38Surgical Procedures, Operative 33camrelizumab 31130-nm albumin-bound paclitaxel 28apatinib 27tislelizumab 26Chemoradiotherapy 26Specimen Handling 25Bevacizumab 24durvalumab 23Albumin-Bound Paclitaxel 23nimotuzumab 22lenvatinib 21Sorafenib 21Platinum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Flow Cytometry × Head & Neck × Clear all
NCT00049140 2014-07-25

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

Duke University

Phase 2 Completed
8 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00589186 2013-12-18

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00690872 2009-06-29

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡